CYXO — Cyxone AB Share News
0.000.00%
Last trade - 00:00- SEK14.25m
- SEK8.44m
Brief: Cyxone Gets Payment Demand Of Just Under SEK 5 Mln
Brief: Cyxone Q2 Loss Before Tax Down At Sek 4.8 Mln
Brief: Cyxone Publishes Outcome Of Rights Issue
Brief: Cyxone Appoints Henrik Hang As Interim CFO
Brief: Cyxone Q1 Loss After Financial Items Narrows To SEK 4.6 Mln
Brief: Cyxone Q4 Pre-Tax Loss Widens To SEK 7.0 Mln
Brief: Cyxone Appoints Malin Lindskog As New CFO
Brief: Cyxone Q3 Pretax Loss SEK 5.2 Million
Brief: Cyxone Receives Intention To Grant From EPO
Brief: Cyxone Q2 Loss Before Tax Narrows To SEK 5.9 Mln
Brief: Cyxone Says Revises Strategy For Commercial Alignment Targeting Valuable Market Opportunities
Brief: Cyxone Gets Intention To Grant From European Patent Office For Divisional Patent Of T20K
Brief: Cyxone Q1 Loss Before Tax Narrows To SEK 6.0 Mln
Brief: Cyxone Receives Patent Approval From US For Salt Forms Of Compound Rabeximod
Brief: Cyxone Proposes Michael Oredsson As New Chairman
Brief: Cyxone Q4 Loss Before Tax Narrows To SEK 6.2 Mln
Brief: Cyxone Receive Ethical, Regulatory Approval From Georgia For Clinical Phase 2B Study In RA
Brief: Cyxone Appoints Carl-Magnus Högerkorp As Permanent CEO
Brief: Cyxone Q3 Loss Before Tax Widens To SEK 11.3 Mln